Literature DB >> 27594756

An Aggressive Form of MALT Lymphoma of the Stomach with Pancreas Infiltration.

Edvin Mulalic1, Samir Delibegovic1.   

Abstract

INTRODUCTION: MALT lymphoma accounts for 7-8% of all B-cell lymphomas and at least 50% of primary gastric lymphoma, with the highest incidence at between 50 and 60 years of age. Aggressive forms are rare, as are indications for multi-visceral resection. CASE STUDY: A patient, 33 years old, was admitted to the tertiary hospital due to a biopsy at a small community hospital confirming adenocarcinoma of the stomach. She was Helicobacter pylori positive. CT showed thickening of the fundus and corpus wall, up to 2.7. cm., with numerous lymph nodes, along the small curvature and in the peripancreatic region, up to 1.5 cm in size. There was close contact between the changed and tumorous posterior wall of the stomach and the anterior surface of the pancreas. Neoplasm of the stomach was found that had infiltrated the body and tail of the pancreas and spleen hilum. Infiltration of the left crura of the diaphragm was also found, ex tempore biopsy showed inflammatory infiltration without elements of neoplasm. Total gastrectomy with omentectomy, and subtotal pancreatectomy and splenectomy were performed. Definitive patho-histological diagnosis confirmed MALT lymphoma of the stomach with pancreas infiltration, but no tumor cells were found on the spleen. Additional staining and immunohistological examination of the specimen from the community hospital showed that this was a misdiagnosis of carcinoma, and the specimen also contained MALT lymphoma. DISCUSSION: MALT lymphoma frequently occurs in the stomach. For patients with MALT, systematic staging is indicated. If MALT is considered in the differential diagnosis, multiple random systematic biopsies within the stomach wall are needed to optimize diagnostic accuracy. Samples should be subject to immune phenotype analysis6. The main tumor cells of MALT are: CD 20+, CD 5-, CD 10-, CD 23-, CD 43+-. It is obvious that this kind of analysis cannot be accomplished in a small community hospital in a poor country such as Bosnia and Herzegovina, and suspicion of MALT indicates referral to a tertiary center. Although the long term risk of transformation of MALT lymphoma into the aggressive form is low9, this case of the aggressive form of MALT indicates the importance of systematic staging.

Entities:  

Keywords:  Helicobacter pylori; Mucosa-associated lymphoid tissue lymphoma; adenocarcinoma

Mesh:

Year:  2016        PMID: 27594756      PMCID: PMC5010062          DOI: 10.5455/medarh.2016.70.235-237

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


1. INTRODUCTION

MALT lymphoma accounts for 7-8% of all B-cell lymphomas and at least 50% of primary gastric lymphomas, with the highest incidence between 50 and 60 years of age (1). Simultaneous occurrence of gastric carcinoma with omental MALT lymphoma is very rare (2). Both primary gastric carcinoma and MALT lymphoma are thought to be associated with H. pylori infection (3). Helicobacter pylorus is an important causative mechanism for the development of gastric MALT syndrome, with a positive rate of 90% in the early phase of gastric MALT syndrome (4). Diagnosis should be confirmed by biopsy. Conventional pinch biopsies may miss the diagnosis, since gastric MALT can infiltrate the submucosa without affecting the mucosa (5). We report a patient with diagnosed gastric carcinoma, but the definitive diagnosis was MALT lymphoma with infiltration of the pancreas. Multivisceral resection of the stomach, pancreas and spleen was performed.

2. CASE REPORT

The patient, 33 years old, was admitted to the tertiary hospital as biopsy had confirmed adenocarcinoma of the stomach. Gastroscopy and biopsy were performed at a small community hospital (Figure 1). She had weight loss and epigastric pain. She was Helicobacter pylori positive. CT showed thickening of the fundus and corpus wall, up to 2.7. cm, with numerous lymph nodes along the small curvature and in the peripancreatic region, up to 1.5 cm. There was close contact between the changed tumorous posterior wall of the stomach and the anterior surface of the pancreas (Figure 2).
Figure 1

The biopsy specimen diagnosed as the adenocarcinoma. The lymphoma cells are centrocyte-like, with clear cytoplasm leading to a mocytoid appearance (HE 20x)

Figure 2

CT thickening of the fundus and corpus wall, up to 2.7 cm.

The biopsy specimen diagnosed as the adenocarcinoma. The lymphoma cells are centrocyte-like, with clear cytoplasm leading to a mocytoid appearance (HE 20x) CT thickening of the fundus and corpus wall, up to 2.7 cm. The patient was transferred to the University hospital. Neoplasm of the stomach was found that infiltrated the body and tail of the pancreas and spleen hilum (Figure 3). Infiltration of the left crura of the diaphragm was also found, and ex tempore biopsy showed inflammatory infiltration, without the elements of neoplasm.
Figure 3

Specimen from the stomach with the body and tail of pancreas and spleen.

Specimen from the stomach with the body and tail of pancreas and spleen. Total gastrectomy with omeentectomy, subtotal pancreatectomy and splenectomy were performed. The postoperative period was normal and the patient was discharged on the tenth day. Definitive patho-histological diagnosis confirmed MALT lymphoma of the stomach with pancreas infiltration, but no tumor cells were found on the spleen. Additional staining and immunohistological examination of the specimen from the community hospital showed that it was a case of the misdiagnosis of carcinoma, and the specimen also contained MALT lymphoma (Figure 4 and 5). Chemotherapy was prescribed for the patient.
Figure 4

Lymphoepithelial lesions. The cells of this MALT lymphoma have clear cytoplasm leading to a monocytoid appearance (HE 40x)

Figure 5

Immunophenotyping shows tumor cell positivity for CD20 B-cell marker (CD20 40x)

Lymphoepithelial lesions. The cells of this MALT lymphoma have clear cytoplasm leading to a monocytoid appearance (HE 40x) Immunophenotyping shows tumor cell positivity for CD20 B-cell marker (CD20 40x)

3. DISCUSSION

MALT lymphoma frequently occurs in the stomach. For patients with MALT, systematical staging is indicated. If MALT is considered in the differential diagnosis, multiple random systematic biopsies within the stomach wall are needed to optimize diagnostic accuracy. Samples should be subject to immune phenotype analysis6. The main tumor cells of MALT are: CD 20+, CD 5-, CD 10-, CD 23-, CD 43+-. It is obvious that this kind of analysis cannot be accomplished in a small community hospital in a poor country such as Bosnia and Herzegovina, and suspicion of MALT indicates referral to a tertiary center. MALT lymphoma is thought to be associated with H. pylori infection (3). Helicobacter pylori infection leads to the formation of lymphoid tissue within the stomach, and lymphomagenesis (6). T cell dependence explains the tendency of gastric MALToma to remain localized in the stomach (7). However, in this case pancreas infiltration was found. Although the long term risk for transformation of MALT lymphoma into the aggressive form is low (8), this case of the aggressive form of MALT indicates the importance of systematic staging. The US National Comprehensive Cancer Network recommends eradication of H. Pylori as the first line of treatment for H. pylori positive gastric MALT lymphoma, and radiotherapy as the second line of treatment for H. Pylori negative or refractory limphoma (9). Surgical resection of the superficial lesion is also an option, with low morbidity, and should be followed with low doses of chemotherapy. However in this case, multivisceral resection was performed without morbidity and mortality, and should be an option in the aggressive form of MALToma.
  8 in total

Review 1.  Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.

Authors:  C Thieblemont; F Berger; C Dumontet; I Moullet; F Bouafia; P Felman; G Salles; B Coiffier
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 2.  Helicobacter pylori in gastric malignancies.

Authors:  Abhishek Bhandari; Sheila E Crowe
Journal:  Curr Gastroenterol Rep       Date:  2012-12

3.  A journey into insidious world of MALT lymphoma of the ileum: from the beginning to the end.

Authors:  Anil Kumar Dhull; Vivek Kaushal; Sunita Singh; Manoj Pal; Amit Lathwal
Journal:  J Gastrointest Oncol       Date:  2014-12

4.  Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.

Authors:  Shotaro Nakamura; Toshiro Sugiyama; Takayuki Matsumoto; Katsunori Iijima; Shouko Ono; Masahiro Tajika; Akira Tari; Yasuhiko Kitadai; Hiroshi Matsumoto; Tadanobu Nagaya; Toshiro Kamoshida; Norihiko Watanabe; Toshimi Chiba; Hideki Origasa; Masahiro Asaka
Journal:  Gut       Date:  2011-09-02       Impact factor: 23.059

5.  Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment.

Authors:  C Y Fung; M L Grossbard; R M Linggood; J Younger; A Flieder; N L Harris; F Graeme-Cook
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

6.  Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients.

Authors:  W Fischbach; W Kestel; T Kirchner; J Mössner; K Wilms
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

7.  Unusual presentation of localized gastric mucosa-associated lymphoid tissue lymphoma mimicking poorly differentiated gastric adenocarcinoma.

Authors:  Yutaka Tomizawa; Michiharu Seki; Masaya Mori
Journal:  Case Rep Gastroenterol       Date:  2012-01-25

8.  Simultaneous occurrence of early gastric carcinoma and mucosa-associated lymphoid tissue lymphoma of the omentum.

Authors:  Tomohiro Murakami; Tuyoshi Shoji; Katsunori Suzuki; Shintaro Ishikawa; Hirotoshi Maruo
Journal:  Case Rep Gastroenterol       Date:  2014-03-21
  8 in total
  1 in total

Review 1.  MALT lymphoma: epidemiology, clinical diagnosis and treatment.

Authors:  Petruta Violeta Filip; Denisa Cuciureanu; Laura Sorina Diaconu; Ana Maria Vladareanu; Corina Silvia Pop
Journal:  J Med Life       Date:  2018 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.